HERTFORDSHIRE, England and
PITTSBURGH, Feb. 14, 2017 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today applauds the rebranding of the Generic
Pharmaceutical Association (GPhA) to the Association for Accessible
Medicines (AAM).
Mylan CEO Heather Bresch
commented, "The launch of GPhA's new brand – the Association for
Accessible Medicines – reflects what we mean to America's
healthcare system. Today, generic medicines are used to fill nearly
90% of prescriptions in the U.S., yet represent only 27% of the
cost. The new name also reflects the dramatic shift in how
healthcare is being delivered in our country, and the increasing
importance for patients approaching the pharmacy counter to
experience the true savings that our medicines provide."
Visit accessiblemeds.org to learn more.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 2,700 generic and branded pharmaceuticals,
including antiretroviral therapies on which approximately 50% of
people being treated for HIV/AIDS in the developing world depend.
We market our products in more than 165 countries and territories.
Our global R&D and manufacturing platform includes more than 50
facilities, and we are one of the world's largest producers of
active pharmaceutical ingredients. Every member of our more than
35,000-strong workforce is dedicated to creating better health for
a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-applauds-the-generic-pharmaceutical-associations-rebrand-to-the-association-for-accessible-medicines-300407225.html
SOURCE Mylan N.V.